Characterizes l-arabinose-utilizing strain, revealing unique traits, indicating potential for bioprocess advancements.
This study reports the physiological and genomic characterization of Corynebacterium glutamicum CS176, a newly isolated strain exhibiting a rare combination of traits: efficient l-arabinose utilization and l-glutamate production without chemical induction, even under excess biotin conditions. Genome analysis of the 3.10 Mb draft sequence (54.20% GC) revealed a 7.8 kb l-arabinose utilization gene cluster highly similar to those of arabinose-assimilating strains, suggesting acquisition via horizontal gene transfer. To link genotype with phenotype, the effects of temperature, oxygen availability, carbon sources, and biotin concentration on bacterial growth and l-glutamate production were systematically evaluated under controlled conditions. Optimal growth was observed at 30–37 °C under high oxygen conditions, whereas maximal l-glutamate production (up to 2.5 g/L in mixed substrates) occurred at 37–39.5 °C under medium–low oxygen conditions. Notably, CS176 maintained l-glutamate production across a wide range of biotin concentrations (0–200 µg/L), in contrast to the typical biotin-dependent regulation observed in C. glutamicum. Furthermore, glucose–arabinose co-utilization enhanced both growth and l-glutamate production, highlighting metabolic flexibility. Together, these findings identify CS176 as a promising strain that overcomes key limitations in conventional glutamate fermentation and provides insights for metabolic engineering and sustainable bioprocess development.
No takes yet. Share an insight, caveat, or question.
Fueangbangluang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: